Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) affects ∼1 in 10 women worldwide. Hypomagnesemia may worsen insulin resistance (IR) due to the role magnesium (Mg) plays in glucose metabolism. This review explores the relation between serum Mg and IR among women with PCOS. A review of primary research focusing on both serum Mg and women with PCOS was conducted from 2011 to 2019. Studies reviewed included human subjects, written in the English language, and limited to community-dwelling women aged ≥18 y. A total of 7 articles were reviewed. The findings from 4 epidemiological analytic studies evaluating serum Mg status suggest there may be a relation between serum Mg concentrations and IR among women with PCOS. However, among the 3 experimental trials, Mg supplementation inconsistently impacted IR among women with PCOS. Women with PCOS are more likely to underconsume Mg-rich foods and have a greater likelihood of lower serum Mg concentrations. Although it remains unclear if dietary Mg and/or supplementation should be a nutritional strategy for all women with PCOS, current research indicates an association between adequate Mg status and improved IR. Further research evaluating dietary interventions and supplementation is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A systematic review of epidemiological studies in women with PCOS indicated a relationship between higher insulin sensitivity and lower magnesium status [145].”
From Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management (2025) · cites this paper as [145]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regarding improved insulin sensitivity and inflammation reduction, magnesium, an essential micronutrient, has been shown to be an important part of nutritional therapy in PCOS [26].”
From Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management (2025) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, findings from RCTs have been inconsistent, with some studies showing improvements in insulin resistance and others failing to demonstrate significant effects.”
The cited source says what the claim attributes to it.
In the citing paper
“Women with PCOS may be more prone to magnesium deficiency and inadequate dietary intake, warranting further research to explore the role of magnesium supplementation in improving insulin resistance and psychological symptoms in this population.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Asemi, Z., Karamali, M., Jamilian, M., Foroozanfard, F., Bahmani, F., Heidarzadeh, Z., Benisi-Kohansal, S., Surkan, P. J., & Esmaillzadeh, A. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.098616 · Cited by 82
RetractedToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 2×
“TABLE 1 Criteria for the diagnosis of polycystic ovary syndrome NIH Consensus, 1990 (2) Rotterdam criteria, 2003 (4) Androgen Excess Society, 2006 (5) Must include all: Must include 2 out of 3: Must include all: Clinical and/or biochemical hyperandrogenism Clinical and/or biochemical hyperandrogenism Clinical and/or b…”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · cited 1×
“Some risk factors, such as prenatal environment and genetics (10) cannot be changed; however, lifestyle factors, including diet, physical activity, and obesity (8, 9) may play a role in disease progression and are modifiable.”
BackgroundBozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526 · cited 1×
“Introduction Polycystic ovary syndrome Polycystic ovary syndrome (PCOS) is a disease that affects 6–10% of females worldwide (1).”
BackgroundMagnesium in Prevention and Therapy
Gröber, U., Schmidt, J., & Kisters, K. (2015) · Nutrients · doi:10.3390/nu7095388 · Cited by 1,061 · cited 5×
“Beyond the role as a cofactor for over 300 enzymes, Mg is essential for both aerobic and anaerobic energy production by glycolysis and oxidative phosphorylation via the Mg-ATP complex or directly as an enzyme activator (12, 16).”
BackgroundInfluentialInsulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929 · cited 1×
“The exact underlying cause of IR remains unclear, however numerous mechanisms have been suggested, including oxidative stress and inflammation, endoplasmic reticulum stress, insulin receptor mutations, and mitochondrial dysfunction (3, 27).”
BackgroundGoodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dsc · Cited by 623
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463 · cited 2×
“Although the exact pathogenesis of PCOS remains unknown (8, 9) researchers believe genetics, intrauterine factors such as androgen exposure and prenatal nutrition, environment and lifestyle, and obesity are all risk factors (8–10).”
BackgroundSimental‐Mendía, L. E., Sahebkar, A., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.019 · Cited by 362 · cited 3×
“In a 2016 systematic review and metaanalysis, researchers evaluated the effect of oral Mg supplementation on insulin sensitivity and glucose control among individuals presenting with and without DM (25).”
BackgroundInfluentialGoodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dscpt2 · Cited by 359
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
Gommers, L. M. M., Hoenderop, J. G. J., Bindels, R. J. M., & de Baaij, J. H. F. (2016) · Diabetes · doi:10.2337/db15-1028 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
Bednarska, S., & Siejka, A. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/59380 · Cited by 284 · cited 2×
“Although the exact pathogenesis of PCOS remains unknown (8, 9) researchers believe genetics, intrauterine factors such as androgen exposure and prenatal nutrition, environment and lifestyle, and obesity are all risk factors (8–10).”
BackgroundThe Importance of Magnesium in Clinical Healthcare
Schwalfenberg, G. K., & Genuis, S. J. (2017) · Scientifica · doi:10.1155/2017/4179326 · Cited by 277
Kostov, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061351 · Cited by 263 · cited 7×
“The presence of Mg ultimately increases ATP receptor sensitivity by increasing tyrosine kinase activity (28, 29).”
BackgroundInfluentialNew markers of insulin resistance in polycystic ovary syndrome
Polak, K., Czyzyk, A., Simoncini, T., & Meczekalski, B. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0523-8 · Cited by 256
Comparison of the Mineral Content of Tap Water and Bottled Waters
Azoulay, A., Garzon, P., & Eisenberg, M. J. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.04189.x · Cited by 242 · cited 1×
“Water, including tap, mineral, and bottled, is a source of Mg, but content varies from 1 mg/L to >120 mg/L depending upon the brand and source (17).”
BackgroundAssessment of magnesium status for diagnosis and therapy.
Elin, R. J. (2010) · PubMed · doi:10.1684/mrh.2010.0213 · Cited by 241 · cited 2×
“07 mg/dL), particularly for individuals with impaired glucose control (12, 13).”
BackgroundRosanoff, A., Dai, Q., & Shapses, S. A. (2016) · Advances in Nutrition · doi:10.3945/an.115.008631 · Cited by 167 · cited 1×
“Excessive doses of vitamin D may increase urinary Mg excretion, as Mg is necessary for the conversion of vitamin D into its active form (11, 19).”
BackgroundImplications of Magnesium Deficiency in Type 2 Diabetes: A Review
Chaudhary, D. P., Sharma, R., & Bansal, D. D. (2010) · Biological Trace Element Research · doi:10.1007/s12011-009-8465-z · Cited by 161 · cited 1×
“Low dietary and serum Mg concentrations as well as an increased Mg urine output are frequently noted among individuals with IR and type 2 diabetes (31).”
BackgroundVeronese, N., Watutantrige-Fernando, S., Luchini, C., Solmi, M., Sartore, G., Sergi, G., Manzato, E., Barbagallo, M., Maggi, S., & Stubbs, B. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.154 · Cited by 153
Hruby, A., Meigs, J. B., O’Donnell, C. J., Jacques, P. F., & McKeown, N. M. (2014) · Diabetes Care · doi:10.2337/dc13-1397 · Cited by 146
Asemi, Z., & Esmaillzadeh, A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0034-1376990 · Cited by 134 · cited 1×
“indicateswomenwithPCOS consume an average of 233mg/d ofMg,which is below theRDAof 320mg/d forwomen aged ≥19 y (33).”
BackgroundChakraborty, P., Ghosh, S., Goswami, S. K., Kabir, S. N., Chakravarty, B., & Jana, K. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9592-5 · Cited by 106 · cited 10×
“05) (raw data for Mg concentrations using mg/dL or mmol/L was not provided) (36).”
BackgroundMethodInfluentialMagnesium status and the metabolic syndrome: A systematic review and meta-analysis
Sarrafzadegan, N., Khosravi‐Boroujeni, H., Lotfizadeh, M., Pourmogaddas, A., & Salehi‐Abargouei, A. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.014 · Cited by 104
Cifelli, C. J., Houchins, J. A., Demmer, E., & Fulgoni, V. L. I. (2016) · Nutrients · doi:10.3390/nu8070422 · Cited by 90 · cited 1×
“It is estimated that over half of Americans do not obtain ample dietary Mg for various reasons, including low concentrations of Mg in processed foods and common dietary staples such as meat, sugar, and white flour (16, 18).”
BackgroundProton pump inhibitor-induced hypomagnesemia: A new challenge
Florentin, M., & Elisaf, M. S. (2012) · World Journal of Nephrology · doi:10.5527/wjn.v1.i6.151 · Cited by 89 · cited 1×
“The FDA suggests clinicians should consider checking serum Mg concentrations prior to initiating PPI therapy for individuals requiring long-term therapy (≥1 y) or with polypharmacy (20).”
BackgroundSerum trace elements and heavy metals in polycystic ovary syndrome
Kurdoğlu, Z., Kurdoğlu, M., Demir, H., & Şahin, H. G. (2011) · Human & Experimental Toxicology · doi:10.1177/0960327111424299 · Cited by 88
Effect of magnesium supplementation on insulin resistance in humans: A systematic review
Morais, J. B. S., Severo, J. S., de Alencar, G. R. R., de Oliveira, A. R. S., Cruz, K. J. C., Marreiro, D. D. N., Freitas, B. D. J. E. S. D. A., de Carvalho, C. M. R., Martins, M. D. C. D. C. E., & Frota, K. D. M. G. (2017) · Nutrition · doi:10.1016/j.nut.2017.01.009 · Cited by 84 · cited 1×
“Mg and IR Mg directly influences glucose metabolism by acting as a cofactor for many enzymes involved in energy metabolism as well as being part of the Mg2+-ATP complex (21).”
BackgroundKanafchian, M., Esmaeilzadeh, S., Mahjoub, S., Rahsepar, M., & Ghasemi, M. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01705-7 · Cited by 80 · cited 6×
“Limitations of the study includedmatching by agewithout consideration of weight or PCOS phenotypes, a relatively small sample size, and no adjustments for potential confounders such as diet or other baseline variables (38).”
BackgroundMethodInfluentialQuantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS)
Szczuko, M., Skowronek, M., Zapałowska-Chwyć, M., & Starczewski, A. (2016) · PubMed · Cited by 79
Association of Serum Magnesium Deficiency with Insulin Resistance in Type 2 Diabetes Mellitus
Chutia, H., & Lynrah, K. G. (2015) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.163131 · Cited by 69
Factors influencing magnesium consumption among adults in the United States
Tarleton, E. K. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy002 · Cited by 66 · cited 5×
“Mg is an abundant mineral found in plant and animal sources as well as drinking water (16).”
BackgroundInfluentialLimitations of insulin resistance assessment in polycystic ovary syndrome
Lewandowski, K. C., Płusajska, J., Horzelski, W., Bieniek, E., & Lewiñski, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0021 · Cited by 35
Jamilian, M., Sabzevar, N. K., & Asemi, Z. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0749-6431 · Cited by 33
Jamilian, M., Maktabi, M., & Asemi, Z. (2017) · PubMed · Cited by 28
Weiss, D., Brunk, D. K., & Goodman, D. A. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1398686 · Cited by 27 · cited 2×
“However, excess supplemental Mg intake can produce diarrhea and rarely, more serious issues such as hypotension, weakness, and confusion (15).”
BackgroundŞıklar, Z., Berberoğlu, M., Çamtosun, E., & Kocaay, P. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.05.006 · Cited by 25 · cited 1×
“It is believed IR is the main pathogenic factor related to the increased rate of metabolic disturbances among women with PCOS (26).”
BackgroundSerum magnesium concentrations and metabolic variables in polycystic ovary syndrome
Kauffman, R. P., Tullar, P., Nipp, R. D., & Castracane, V. D. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2010.01067.x · Cited by 22 · cited 9×
“The results indicate women with IR + PCOS have a clinically significant lower serumMg concentration than women with NIR + PCOS (35).”
BackgroundMethodInfluentialMuneyyirci‐Delale, O., Kaplan, J., Joulak, I., Yang, L., von Gizycki, H., & Nacharaju, V. L. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.769515 · Cited by 19 · cited 10×
“Although researchers noted Mg supplementation did not produce significant outcomes, the researchers did not evaluate baseline serum Mg among participants (39).”
BackgroundMethodInfluentialVeronese, N., Watutantrige‐Fernando, S., Luchini, C., Solmi, M., Sartore, G., Sergi, G., Manzato, E., Barbagallo, M., Maggi, S., & Stubbs, B. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.209 · Cited by 19
von Ehrlich, B., Barbagallo, M., Classen, H. G., Guerrero‐Romero, F., Mooren, F. C., Rodríguez‐Morán, M., Vierling, W., Vormann, J., & Kisters, K. (2017) · Trace Elements and Electrolytes · doi:10.5414/tex01473 · Cited by 15
Study of Magnesium levels in Polycystic Ovarian Syndrome
Rajeswari, G., Gopal, P. S., Veerabhadrudu, B., & Suresh, E. (2016) · International Journal of Advances in Scientific Research · doi:10.7439/ijasr.v2i2.2870 · Cited by 13
von Ehrlich, B., Barbagallo, M., Classen, H. G., Guerrero‐Romero, F., Mooren, F. C., Rodríguez‐Morán, M., Vierling, W., Vormann, J., & Kisters, K. (2014) · Diabetologie und Stoffwechsel · doi:10.1055/s-0034-1366398 · Cited by 10
Research works printed but not linked: 1
- Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 1997. 23115811
Cited by
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
“…et al. 2019 [221] Magnesium 1 SR 3 RCT; 156 Serum magnesium con‑ centrations were associated with IR but supplementa‑ tion had inconsistent effects Hamilton et al. 2019 [222] Chromium Picolinate 2 SR/MA 11 RCT; 702 ↓ BMI [223], FINS [223], IR [224], T [223] ↑ T [224] ↔ BMI [224], FG…”
BackgroundResultNutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome
Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A. (2022) · Advances in Nutrition · doi:10.1093/advances/nmab141 · Cited by 146
Female Fertility and the Nutritional Approach: The Most Essential Aspects
Skoracka, K., Ratajczak, A. E., Rychter, A. M., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab068 · Cited by 208
“The proper serum concentration of magnesium is probably associated with increased insulin sensitivity of tissues (130, 131).”
BackgroundMousavi, R., Alizadeh, M., Jafarabadi, M. A., Heidari, L., Nikbakht, R., Babaahmadi‐Rezaei, H., & Karandish, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02725-y · Cited by 113
“On the other hand, there is a straight relationship between hypomagnesemia and PCOS status [25].”
BackgroundShen, H., Xu, X. L., & Li, X. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00684-y · Cited by 87
“Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 4–10% of the women of reproductive age [1, 2].”
Background
Metadata
- Authors
- Hamilton, K. P., Zelig, R., Parker, A. R., & Haggag, A.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Anaheim Clinical Trials (US)
- Corresponding author
- Hamilton, Kristen P
- ORCID
- Zelig, Rena
- Venue
- Current Developments in Nutrition
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 3
- Issue
- 11
- Pages
- nzz108
- ISSN
- 2475-2991 (ISSN-L)
- PMC
- PMC6822014
- OpenAlex
- W2979256824
- Cited by
- 41
- References
- 47
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 14 · 2020: 2
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1169 d)
- Locations
- Current Developments in Nutrition (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, insulin resistance, serum magnesium, hypomagnesemia, magnesium supplementation, dietary magnesium, magnesium status, glucose metabolism, women
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
